Aluminum Zirconium Octachlorohydrex Gly

證據等級: L5

預測適應症: 0 個

Aluminum Zirconium Octachlorohydrex Gly: No TxGNN Repurposing Prediction Available

One-Sentence Summary

Aluminum Zirconium Octachlorohydrex Gly is an inorganic salt complex primarily known as an active ingredient in antiperspirant consumer products, functioning by temporarily occluding sweat ducts to reduce perspiration. No TxGNN repurposing prediction is available for this compound at this time — it does not appear in pharmaceutical drug databases with an approved indication, preventing model scoring. As a result, no supporting clinical trial or literature evidence for a new indication could be retrieved.

Quick Overview

Item	Content
Original Indication	No pharmaceutical indication registered
Predicted New Indication	None — no TxGNN prediction available
TxGNN Prediction Score	N/A
Evidence Level	N/A
US Market Status	Not marketed (as a pharmaceutical drug)
Number of NDAs	0
Recommended Decision	Hold

Why is This Prediction Reasonable?

No TxGNN repurposing prediction was generated for this compound. Aluminum Zirconium Octachlorohydrex Gly is a cosmetic/OTC active ingredient regulated under antiperspirant monographs (e.g., FDA OTC monograph), not as a prescription pharmaceutical. Because it carries no DrugBank ID and no approved pharmaceutical indication in regulatory databases, the TxGNN graph model cannot anchor this compound to a drug node in the knowledge graph — making prediction impossible in the current pipeline.

Without a confirmed DrugBank ID or an established pharmaceutical indication, any mechanistic basis for drug repurposing cannot be evaluated. The DrugBank query returned one result (query log entry #3), but the matched record was not captured in the Evidence Pack, suggesting a partial or low-confidence match that warrants manual verification before proceeding.

Safety Considerations

Please refer to the product’s safety data sheet and applicable regulatory guidance for safety information.

Conclusion and Next Steps

Decision: Hold

Rationale: This compound has no pharmaceutical regulatory profile, no DrugBank ID, and no TxGNN prediction — it cannot enter the standard repurposing evaluation workflow in its current state.

To proceed, the following is needed:

Manually inspect the DrugBank query result (1 record found) to confirm whether a valid DrugBank ID can be assigned
Verify whether this compound has any documented pharmaceutical (non-cosmetic) use case that would justify inclusion in the TxGNN pipeline
Re-run the TxGNN prediction with the confirmed DrugBank drug node if a valid mapping is established
Clarify the original intent: if this compound was included by error (e.g., mistaken as a pharmaceutical active), it should be removed from the candidate list
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.